The levels of non-heme iron in thalassemia red blood cell membrane treated with 6-shogaol-rich ginger extract at concentrations of 50, 100, and 200 µg/mL. by Hataichanok Chuljerm (19144293)

Suppression of Mif and CD74 down-regulates p-ERK signaling after apoptosis induction. by Safia A. Essien (20108379)

Induction of RoxS leads to decreased <i>ppnKB</i> mRNA levels. Northern blot showing decreased <i>ppnKB</i> mRNA levels upon RoxS induction. by Sylvain Durand (67030)

Progressive decrease in expression of Kcnj10, Kcnq1, Gjb2 and Gjb6 in <i>Spns2^tm1a/tm1a</i> mice. by Jing Chen (4762)

M1-37T protein is degraded in a lysosome-independent manner, and its ubiquitination is not through K48 linkage. by Chenxi Wang (284364)

M1 protein harboring T37 is susceptible to ubiquitination at K187. by Chenxi Wang (284364)

M1 protein with T37A mutation confers increased pathogenicity and replication of H9N2 virus in mice. by Chenxi Wang (284364)

Stability of the H9N2 M1 protein of BJ/3/99 virus is increased by the T37A mutation. by Chenxi Wang (284364)

HBV RNaseH inhibitors effects on capsid accumulation occur independent of HBV DNA synthesis. by Daniel P. Bradley (10306893)

The T37A substitution increases both H5N6 M1 protein stability and H5N6 viral replication in mammals. by Chenxi Wang (284364)

Compound 390 induces HBV capsid accumulation via an ROS-mediated mechanism. by Daniel P. Bradley (10306893)

1466 does not change total yield of capsids during biochemical assembly reactions. by Daniel P. Bradley (10306893)

1466 slows the capsid assembly rate in biochemical Cp149 capsid assembly reactions. by Daniel P. Bradley (10306893)

1466 inhibits capsid accumulation independent of HBV replication. by Daniel P. Bradley (10306893)

Screening HBV RNaseH inhibitors in HepDES19 cell for effects on capsids and core protein. by Daniel P. Bradley (10306893)

αHT compound 390 does not affect intracellular capsid accumulation or encapsidated HBV RNA levels in HepG2.2.15 cells. by Daniel P. Bradley (10306893)

Compound structures and preferential inhibition of the HBV plus-polarity DNA strand. by Daniel P. Bradley (10306893)

DataSheet_1_Efficacy and Safety of Lactobacillus plantarum K50 on Lipids in Koreans With Obesity: A Randomized, Double-Blind Controlled Clinical Trial.docx by Minji Sohn (4166143)

“…Background<p>Only few studies have investigated the role of probiotics in the development of obesity. We aimed to determine the efficacy and safety of an intake of Lactobacillus plantarum K50 (LPK) on body fat and lipid profiles in people with obesity.…”

Random Forest structure with cross-validation. by Mingyue Sun (4638535)

Pharmacokinetic models and concentrations predictions of treatments considered. by Guillaume Lingas (9955528)